BioCentury | Oct 8, 2020
Product Development

Mapping opportunities for China’s early cancer detection boom

...has definitely demonstrated more forward thinking with regard to healthcare expenditure.” Victor Tong, Decheng Capital AnchorDx Corp....
...American Association for Cancer Research (AACR). Like Grail, both companies’ tests detect methylation signatures in ctDNA.AnchorDx...
...while the larger biotech spent time evaluating which type of analyte gave the best signal, AnchorDx...
BioCentury | Sep 28, 2018
Clinical News

Sensitivity of Berry Genomics' early HCC screen exceeds 90%

...eight Chinese companies developing NGS tests for early cancer detection including SeekIn Cancer (Shenzhen, China), AnchorDx Corp....
BioCentury | Sep 24, 2018
Clinical News

Sensitivity of Berry Genomics' early HCC screen exceeds 90%

...eight Chinese companies developing NGS tests for early cancer detection including SeekIn Inc. (Shenzhen, China), AnchorDx Corp....
...prevalence is higher in China than the U.S., in part due to undiagnosed hepatitis. Jaime De Leon AnchorDx Corp. Berry...
BioCentury | Sep 21, 2018
Product R&D

China’s rising genomics start-ups

...phenotypic and behavioral data from its users, and makes nutrition, exercise or product recommendations $154 AnchorDx Corp....
BioCentury | Dec 7, 2017
Financial News

6 Dimensions raises $844.3M across two funds

...series B rounds for immunotherapy company Medeor Therapeutics Inc. (San Mateo, Calif.), medical technology play AnchorDx Corp....
BioCentury | Nov 10, 2017
Financial News

AnchorDx raises $28M in series B

...Medical technology play AnchorDx Corp. (Guangzhou, China) raised $28 million in a series B round led by...
...Clinical Laboratory Co. Ltd. (Guangzhou, China) also participated, as did existing investor Marathon Venture Partners. AnchorDx's...
...invested in AnchorDx's series A round. The start-up was founded in 2015. AnchorDx Corp., Guangzhou, China Allison Johnson AnchorDx Corp. Arch...
BioCentury | Nov 7, 2017
Financial News

AnchorDx raises $28M in series B round

...Medical technology play AnchorDx Corp. (Guangzhou, China) raised $28 million in a series B round led by...
...Clinical Laboratory Co. Ltd. (Guangzhou, China) also participated, as did existing investor Marathon Venture Partners. AnchorDx's...
...BioVentures merged this year to form 6 Dimensions Capital. Northern Light Venture Capital invested in AnchorDx's...
Items per page:
1 - 7 of 7
BioCentury | Oct 8, 2020
Product Development

Mapping opportunities for China’s early cancer detection boom

...has definitely demonstrated more forward thinking with regard to healthcare expenditure.” Victor Tong, Decheng Capital AnchorDx Corp....
...American Association for Cancer Research (AACR). Like Grail, both companies’ tests detect methylation signatures in ctDNA.AnchorDx...
...while the larger biotech spent time evaluating which type of analyte gave the best signal, AnchorDx...
BioCentury | Sep 28, 2018
Clinical News

Sensitivity of Berry Genomics' early HCC screen exceeds 90%

...eight Chinese companies developing NGS tests for early cancer detection including SeekIn Cancer (Shenzhen, China), AnchorDx Corp....
BioCentury | Sep 24, 2018
Clinical News

Sensitivity of Berry Genomics' early HCC screen exceeds 90%

...eight Chinese companies developing NGS tests for early cancer detection including SeekIn Inc. (Shenzhen, China), AnchorDx Corp....
...prevalence is higher in China than the U.S., in part due to undiagnosed hepatitis. Jaime De Leon AnchorDx Corp. Berry...
BioCentury | Sep 21, 2018
Product R&D

China’s rising genomics start-ups

...phenotypic and behavioral data from its users, and makes nutrition, exercise or product recommendations $154 AnchorDx Corp....
BioCentury | Dec 7, 2017
Financial News

6 Dimensions raises $844.3M across two funds

...series B rounds for immunotherapy company Medeor Therapeutics Inc. (San Mateo, Calif.), medical technology play AnchorDx Corp....
BioCentury | Nov 10, 2017
Financial News

AnchorDx raises $28M in series B

...Medical technology play AnchorDx Corp. (Guangzhou, China) raised $28 million in a series B round led by...
...Clinical Laboratory Co. Ltd. (Guangzhou, China) also participated, as did existing investor Marathon Venture Partners. AnchorDx's...
...invested in AnchorDx's series A round. The start-up was founded in 2015. AnchorDx Corp., Guangzhou, China Allison Johnson AnchorDx Corp. Arch...
BioCentury | Nov 7, 2017
Financial News

AnchorDx raises $28M in series B round

...Medical technology play AnchorDx Corp. (Guangzhou, China) raised $28 million in a series B round led by...
...Clinical Laboratory Co. Ltd. (Guangzhou, China) also participated, as did existing investor Marathon Venture Partners. AnchorDx's...
...BioVentures merged this year to form 6 Dimensions Capital. Northern Light Venture Capital invested in AnchorDx's...
Items per page:
1 - 7 of 7